Biosimilar Manufacturing solution center
-
Implementing And Optimizing Your eQMS
8/25/2026
This article addresses everything that follows the signed contract for an eQMS: how a system is configured, validated, adopted, and maintained.
-
Chromatography Equipment Maintenance In An Era Of Acceleration
8/19/2026
As chromatography systems become more sophisticated, maintenance directly influences uptime. Learn why coordinated maintenance strategies are essential for supporting complex analytical work.
-
Why You Need Spare Parts On Hand For Pharma And Lab Equipment
8/19/2026
Advanced spare parts planning can reduce downtime. Learn why precise component specifications matter and how seemingly identical parts can differ significantly in quality, performance, and failure risk.
-
Benefits Of Preventive Maintenance For Pharma Manufacturing
8/19/2026
Preventive maintenance helps reduce equipment failures. Learn why regular service schedules are becoming even more important as biopharmaceutical production shifts toward continuous processing.
-
A Much-Improved Approach For Understanding And Managing Safety Risks
8/18/2026
Learn how causal mechanism and effect analysis (CMEA) and its principles can be used to develop and maintain safer working environments in the pharma/biotech and medical device industries.
-
Bioprocessing Observability: Why Real-Time Monitoring Matters
8/17/2026
Bioprocessing produces more data than ever, but many organizations still struggle to turn it into action. Better integration can support faster decisions and more predictable performance.
-
The Bioprocessing Industry Has A Digital Execution Problem
8/17/2026
Digital execution remains a major barrier in manufacturing. Learn how fragmented data, manual decisions, and inconsistent adoption affect the ability to bring complex therapies to patients faster.
-
How Can Biopharma Overcome Digital Transformation Failure?
8/17/2026
Biopharma understands the promise of digital transformation, but implementation remains the challenge. Learn why organizational structures must evolve to turn strategies into scalable results.
-
CSV Assumes The AI System Sits Still — It Doesn't.
8/17/2026
The computer system validation playbook was written for software that holds its shape. AI doesn't. Validating it has to become an act of governance.
-
July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing
8/7/2026
Mathini Ilancheran updates us on how delayed U.S. tariffs on generic drug imports could reshape supply, sourcing, and trial planning.